In contrast to BCOR’s role as a tumor suppressor in leukemia, activating BCOR alterations and translocations are common in pediatric sarcomas and CNS neuroectodermal tumors (CNS HGNET-BCOR), which have transcriptional profiles reminiscent of BCOR overexpression (160). Here, BCOR is linked to leukemia.